Rikova K (2009) CST Curation Set: 8505; Year: 2009; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[ST]P

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S35-p - ACTA1 (human) ▲

Modsite: APrAVFPsIVGRPRH SwissProt Entrez-Gene Orthologous residues ACTA1 (human): S35‑p, ACTA1 (mouse): S35‑p, ACTA1 (rat): S35‑p, ACTA1 (rabbit): S35‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S35-p - ACTA2 (human) ▲
Modsite: APrAVFPsIVGRPRH SwissProt Entrez-Gene Orthologous residues ACTA2 (human): S35‑p, ACTA2 (mouse): S35‑p, ACTA2 (rat): S35‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S33-p - ACTB (human) ▲
Modsite: APrAVFPsIVGRPRH SwissProt Entrez-Gene Orthologous residues ACTB (human): S33‑p, ACTB (mouse): S33‑p, ACTB (rat): S33‑p, ACTB (cow): S33‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S35-p - ACTC1 (human) ▲
Modsite: APrAVFPsIVGRPRH SwissProt Entrez-Gene Orthologous residues ACTC1 (human): S35‑p, ACTC1 (mouse): S35‑p, ACTC1 (rat): S35‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S33-p - ACTG1 (human) ▲
Modsite: APrAVFPsIVGRPRH SwissProt Entrez-Gene Orthologous residues ACTG1 (human): S33‑p, ACTG1 (mouse): S33‑p, ACTG1 (rat): S33‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S34-p - ACTG2 (human) ▲
Modsite: APrAVFPsIVGRPRH SwissProt Entrez-Gene Orthologous residues ACTG2 (human): S34‑p, ACTG2 (mouse): S34‑p, ACTG2 (rat): S34‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S6-p - DACT3 (human) ▲
Modsite: __MIRAFsFPVsPER SwissProt Entrez-Gene Orthologous residues DACT3 (human): S6‑p, DACT3 (mouse): S6‑p, DACT3 (rat): S6‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S170-p - MARCKS (human) ▲

Modsite: sFkLsGFsFkKNKkE SwissProt Entrez-Gene Orthologous residues MARCKS (human): S170‑p, MARCKS (mouse): S163‑p, MARCKS (rat): S163‑p, MARCKS (chicken): S135‑p, MARCKS (cow): S169‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S4613-p - Plectin-1 (human) ▲

Modsite: QsTkGyysPysVsGs SwissProt Entrez-Gene Orthologous residues Plectin‑1 (human): S4613‑p, Plectin‑1 iso2 (human): S4503‑p, Plectin‑1 iso3 (human): S4499‑p, Plectin‑1 iso4 (human): S4476‑p, Plectin‑1 iso5 (human): S4476‑p, Plectin‑1 iso6 (human): S4480‑p, Plectin‑1 iso8 (human): S4454‑p, Plectin‑1 iso9 (human): S4462‑p, Plectin‑1 (mouse): S4620‑p, Plectin‑1 iso3 (mouse): S4472‑p, Plectin‑1 iso6 (mouse): S4501‑p, Plectin‑1 (rat): S4616‑p, Plectin‑1 iso2 (rat): S4473‑p, Plectin‑1 (cow): S4573‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S733-p - POTE2 (human) ▲
Modsite: APrAVFPsIVGRPRQ SwissProt Entrez-Gene Orthologous residues POTE2 (human): S733‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S733-p - POTEF (human) ▲
Modsite: APrAVFPsIVGRPRQ SwissProt Entrez-Gene Orthologous residues POTEF (human): S733‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human

S733-p - POTEI (human) ▲
Modsite: APrAVFPsIVGRPRQ SwissProt Entrez-Gene Orthologous residues POTEI (human): S733‑p Characterization Methods used to characterize site in vivo:  mass spectrometry Disease tissue studied:  lung cancer, non-small cell lung cancer Relevant cell lines - cell types - tissues:  lung Cellular systems studied:  tissue Species studied:  human